Video

Probiotics in focus: key clinical and translational papers shaping the field

Francisco Guarner Aguilar reviewed some of the most significant probiotic-related papers published in recent years, spanning basic research, clinical trials, and population-based studies.

Finding missing human gut microbes in the Amazon: culturing the Yanomami microbiome for future probiotics

Emma Allen-Vercoe, from University of Guelph (Canada) focuses on the gut microbiome of the Yanomami, whose exceptionally strong cardiometabolic health has attracted growing scientific interest.

From dysbiosis to long-term outcomes: Flavia Indrio wraps up PPPP 2026

Prof. Flavia Indrio reflects on the main take-home messages from the congress, which brought together 32 leading international experts in microbiota research, allergy, nutrition, gut-brain axis and lung disease.

When microbiomes turn risky: a one health view of infective competence

Paul Wilmes, University of Luxembourg, explores the concept of infective competence within a One Health framework.

A whole-tomato approach to functional nutrition, inflammation, and microbiome modulation

Piergiorgio Natali (Mediterranean Task force for Cancer Control) discusses the importance of improving functional foods as a strategy to support health, particularly during aging.

Beyond sequencing: the role of translational research in functional microbiome profiling

Lorenza Putignani, Pediatric Hospital Bambino Gesù, Italy, discusses translational research in the microbiome field.

The gut microbiome: emerging therapeutic perspectives in multiple sclerosis and type 1 diabetes

Marika Falcone of San Raffaele Hospital in Milan discusses the growing evidence linking the gut microbiome to extra-intestinal autoimmune diseases.

Microbiome innovation meets space exploration: a new frontier for human adaptation

Pierre Burguière, founder of Microbiome Futures, and Christian Roghi, founder of Bridgyz, reflect on a groundbreaking Pharmabiotics 2026 session dedicated to the intersection of microbiome science and space exploration.

IBD and the microbiome: between biological complexity and emerging therapeutic signals

Maurizio Vecchi, gastroenterologist at Policlinico of Milan (Italy), discussed the current and potential role of the microbiome in inflammatory bowel disease (IBD).

Oral Microbiome: a new window on systemic health—and a clinical opportunity for evidence-based probiotics

Gianfranco Grompone, Chief Scientific Officer at BioGaia GA, discusses the new evidences about oral microbiome.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.